Stroke, Lacunar: Clinical Trials

2 trials for Stroke, Lacunar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 31Completed 1

Follow Stroke, Lacunar: new trials by email Literature Review of Stroke, Lacunar trials Research Report on Stroke, Lacunar

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LACunar Intervention (LACI-2) Trial-2
Isosorbide Mononitrate XL (ISMN), Cilostazol, ISMN XL and Cilostazol - Cerebral Small Vessel Diseases, Stroke, Lacunar
Phase 2 / Phase 3CompletedUniversity of Edinburgh3632018-01-082024-11-12
Effect of Tadalafil on Cerebral Large Arteries in Stroke
Tadalafil, Placebo - Stroke, Lacunar, Cerebral Small Vessel Diseases
Phase 2CompletedChristina Kruuse202016-11-292017-08-22

Narrower conditions

Cerebral Small Vessel Diseases (2)  ·  Alzheimer Disease (1)  ·  Dementia (1)

Broader conditions

Brain Diseases (2)  ·  Brain Infarction (2)  ·  Cardiovascular Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Cerebrovascular Disorders (2)  ·  Infarction (2)  ·  Ischemia (2)  ·  Ischemic Stroke (2)  ·  Necrosis (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Stroke (2)  ·  Thrombotic Stroke (2)  ·  Vascular Diseases (2)

Interventions

Cilostazol (1)  ·  Tadalafil (1)

Sponsors

Christina Kruuse (1)  ·  University of Edinburgh (1)

Countries

Denmark (1)  ·  United Kingdom (1)

Top investigators

Christina R Kruuse, MD, PhD (1)  ·  Joanna M Wardlaw, MB ChB (1)

Results publications

PMID 35833913, PMID 37222252

NIH funding

2016 (2)